Nivolumab-induced chronic inflammatory demyelinating polyradiculoneuropathy mimicking rapid-onset Guillain–Barré syndrome: a case reportRyota Tanaka, Manabu Fujimoto, Hiroshi Maruyama et al.|Japanese Journal of Clinical Oncology|2016Cited by 82
Anti-nuclear matrix protein 2 antibody-positive inflammatory myopathies represent extensive myositis without dermatomyositis-specific rashYuki Ichimura, Naoko Okiyama, Risa Konishi et al.|Lara D. Veeken|2021Cited by 61
Severe hepatitis arising from ipilimumab administration, following melanoma treatment with nivolumabRyota Tanaka, Manabu Fujimoto, Yasuhiro Fujisawa et al.|Japanese Journal of Clinical Oncology|2016Cited by 56
Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Regulates Epidermal Keratinization under Psoriatic Skin InflammationTatsuya Ogawa, Manabu Fujimoto, Yosuke Ishitsuka et al.|American Journal Of Pathology|2020Cited by 43
Intravenous immunoglobulin contributes to the control of antimelanoma differentiation‐associated protein 5 antibody‐associated dermatomyositis with palmar violaceous macules/papulesHanako Koguchi‐Yoshioka, Manabu Fujimoto, Naoko Okiyama et al.|British Journal of Dermatology|2017Cited by 38